Article Information
History
- November 5, 2020.
Article Versions
- Version 1 (August 2, 2020 - 01:51).
- Version 2 (August 7, 2020 - 15:00).
- You are currently viewing Version 3 of this article (November 5, 2020 - 11:48).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Anil Gulati1,*,
- Rajat Choudhuri2,
- Ajay Gupta3,
- Saurabh Singh4,
- S. K. Noushad Ali5,
- Gursaran Kaur Sidhu6,
- Parvez David Haque7,
- Prashant Rahate8,
- Aditya R Bothra9,
- G P Singh10,
- Sanjeev Maheshwari11,
- Deepak Jeswani12,
- Sameer Haveri13,
- Apurva Agarwal14 and
- Nilesh Radheshyam Agrawal15
- 1Pharmazz, Inc
- 2Institute of Postgraduate Medical Education & Research/SSKM Hospital, Kolkata, India
- 3Chiranjeev Medical Ctr, Jhansi, India
- 4Inst of Medical Sciences, Banaras Hindu Univ, Varanasi, India
- 5ACSR Government Medical Coll & Hosp, Nellore, India
- 6Sidhu Hosp Pvt. Ltd., Ludhiana, India
- 7Christian Medical Coll & Hosp, Ludhiana, India
- 8Seven Star Hosp, Nagpur, India
- 9Rahate Surgical Hosp & ICU, Nagpur, India
- 10King Georges Medical Univ, Lucknow, India
- 11Jawahar Lal Nehru Medical Coll & Attached Hosp, Ajmer, India
- 12Criticare Hosp & Res Inst, Nagpur, India
- 13KLEs Dr. Prabhakar Kore Hosp & Medical Res Ctr, Belgaum, India
- 14GSVM Medical Coll, Kanpur, India
- 15New Era Hosp & Res Inst, Nagpur, India
- ↵*Corresponding author; email: anil.gulati{at}pharmazz.com
Posted November 05, 2020.
A multicentric, randomized, controlled phase III study of centhaquine (Lyfaquin®) as a resuscitative agent in hypovolemic shock patients
